Story
PepsiCo to End Coverage for Weight-Loss Drugs Like Wegovy, Zepbound Citing Costs

PepsiCo Inc. (NASDAQ:PEP) plans to stop covering popular weight-loss drugs in its employee health insurance plans beginning in October, citing the rapidly increasing expense of these treatments, according to a report from Bloomberg.
A Cost-Driven Decision
In an email to some employees reviewed by Bloomberg News, the company stated that the change was necessary to manage costs. The email, sent by pharmacy benefit manager Express Scripts, a unit of Cigna Group (NYSE:CI), noted that prescription weight-loss medications have become one of the fastest-growing costs in PepsiCo's health plans.
"Removing coverage for prescription weight-loss drugs enables us to maintain a healthcare program that is sustainable and affordable for all PepsiCo employees," the communication said, according to the report. The decision affects blockbuster GLP-1 drugs such as Wegovy from Novo Nordisk A/S (NYSE:NVO) and Zepbound from Eli Lilly & Co. (NYSE:LLY).
Broader Industry Trend
AdPepsiCo's move is not an isolated event but reflects a wider trend among U.S. employers and insurance providers. Many are re-evaluating or scaling back coverage for this new class of highly effective but expensive anti-obesity medications.
While demand for these drugs remains exceptionally high, their long-term cost has become a significant concern for the entities that pay for them. This creates a challenging dynamic for pharmaceutical companies, which are seeing massive revenue growth but also facing increasing pushback from payers on pricing and reimbursement.
Implications for Employees
Under the new policy, PepsiCo employees who wish to continue using these medications will need to pay for them outside of the company's insurance plans. The email reportedly suggested that alternative payment options may be available, stating that "many commonly used weight-loss medications now have cash-pay affordability pathways that were not available previously to individual patients."
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.